Strain identifier

BacDive ID: 8315

Type strain: No

Species: Mycobacterium smegmatis

Strain history: <- K. Kieslich, Schering 215 <- ATCC <- L.F. Bojalil, W-113 <- S. A. Waksman, 113 <- ATCC <- Hyg. Lab., Washington DC, 178 (Bacillus smegmatis)

NCBI tax ID(s): 1772 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 9 (current version):
version 8.1:
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 9 (current version)

General

@ref: 10921

BacDive-ID: 8315

DSM-Number: 43277

keywords: 16S sequence, Bacteria, human pathogen

description: Mycobacterium smegmatis DSM 43277 is a human pathogen of the family Mycobacteriaceae.

NCBI tax id

  • NCBI tax id: 1772
  • Matching level: species

strain history

  • @ref: 10921
  • history: <- K. Kieslich, Schering 215 <- ATCC <- L.F. Bojalil, W-113 <- S. A. Waksman, 113 <- ATCC <- Hyg. Lab., Washington DC, 178 (Bacillus smegmatis)

doi: 10.13145/bacdive8315.20240510.9

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Mycobacteriales
  • family: Mycobacteriaceae
  • genus: Mycobacterium
  • species: Mycobacterium smegmatis
  • full scientific name: Mycobacterium smegmatis (Trevisan 1889) Lehmann and Neumann 1899 (Approved Lists 1980)
  • synonyms

    @refsynonym
    20215Bacillus smegmatis
    20215Mycolicibacterium smegmatis

@ref: 10921

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Actinomycetales

family: Mycobacteriaceae

genus: Mycobacterium

species: Mycobacterium smegmatis

full scientific name: Mycobacterium smegmatis (Trevisan 1889) Lehmann and Neumann 1899 emend. Nouioui et al. 2018

type strain: no

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
10921MIDDLEBROOK MEDIUM (DSMZ Medium 645)yeshttps://mediadive.dsmz.de/medium/645Name: MIDDLEBROOK MEDIUM (DSMZ Medium 645) Composition: Bacto Middlebrook 7H10 agar 20.9945 g/l Glycerol Distilled water
10921LÖWENSTEIN-JENSEN MEDIUM (DSMZ Medium 354)yeshttps://mediadive.dsmz.de/medium/354Name: LÖWENSTEIN-JENSEN MEDIUM (DSMZ Medium 354) Composition: Potato flour 18.6104 g/l L-Asparagin 2.23325 g/l KH2PO4 1.55087 g/l Mg-citrate 0.372208 g/l Malachite green 0.248139 g/l MgSO4 0.148883 g/l Glycerol Fresh egg mixture Distilled water

culture temp

  • @ref: 10921
  • growth: positive
  • type: growth
  • temperature: 37

Safety information

risk assessment

  • @ref: 10921
  • pathogenicity human: yes
  • pathogenicity animal: yes
  • biosafety level: 2
  • biosafety level comment: Risk group (German classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Mycobacterium smegmatis strain ATCC 14468 16S ribosomal RNA gene, partial sequenceJQ348119206nuccore1772
20218M.smegmatis 16S ribosomal RNA geneM59281148nuccore1772
20218Mycobacterium smegmatis 16S rRNA geneX529221454nuccore1772

External links

@ref: 10921

culture collection no.: DSM 43277, ATCC 101, ATCC 14468, NCIB 9953, NCTC 10265, TMC 1546

straininfo link

  • @ref: 77717
  • straininfo: 46517

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity228161Interaction between 30 S ribosomal components in a viomycin resistant mutant of Mycobacterium smegmatis.Mizuguchi Y, Suga K, Yamada TMicrobiol Immunol10.1111/j.1348-0421.1979.tb00500.x1979Chemical Phenomena, Chemistry, Drug Resistance, Microbial, Kanamycin/pharmacology, Mycobacterium/*drug effects/genetics, Protein Biosynthesis, Recombination, Genetic, Ribosomes/*drug effects, Streptomycin/pharmacology, Viomycin/*pharmacology
Enzymology464582Purification, properties, and cytotoxic effect of a bacteriocin from Mycobacterium smegmatis.Saito H, Watanabe T, Tomioka HAntimicrob Agents Chemother10.1128/AAC.15.4.5041979Antineoplastic Agents, Bacteriocins/analysis/*isolation & purification, Chemical Phenomena, Chemistry, Molecular Weight, Mycobacterium/*analysis/drug effectsPhylogeny
Pathogenicity498138Effect of a bacteriocin produced by Mycobacterium smegmatis on growth of cultured tumor and normal cells.Saito H, Watanabe TCancer Res1979Adsorption, Animals, Bacteriocins/metabolism/*pharmacology, Cell Division/*drug effects, Cell Line, Cell Membrane/metabolism, Cell Transformation, Neoplastic, Cricetinae, Humans, Mice, *Mycobacterium, Neoplasms, Experimental/*drug therapy, Rats, Tumor Virus Infections/drug therapyMetabolism
Metabolism1653167Calmodulin-like protein and the phospholipids of Mycobacterium smegmatis.Burra SS, Reddy PH, Falah SM, Venkitasubramanian TA, Murthy PSFEMS Microbiol Lett10.1016/0378-1097(91)90593-y1991Calcium/physiology, Calmodulin/*analysis/physiology, Cyclic AMP/analysis, Glucose/pharmacology, Mycobacterium/*analysis, Phospholipids/*analysis/metabolism
Enzymology2667997Modulation of arginine decarboxylase activity from Mycobacterium smegmatis. Evidence for pyridoxal-5'-phosphate-mediated conformational changes in the enzyme.Balasundaram D, Tyagi AKEur J Biochem10.1111/j.1432-1033.1989.tb14934.x1989Apoenzymes/metabolism, Arginine/metabolism, Carboxy-Lyases/isolation & purification/*metabolism, Chromatography, Gel, Dialysis, Electrophoresis, Polyacrylamide Gel, Escherichia coli/enzymology, Hydrogen-Ion Concentration, Kinetics, Molecular Weight, Mycobacterium/*enzymology, Protein Conformation/drug effects, Protein Denaturation, Pyridoxal Phosphate/metabolism/*pharmacology, SpectrophotometryMetabolism
Enzymology3342242Purification and properties of aspartate transcarbamylase from Mycobacterium smegmatis.Masood R, Venkitasubramanian TABiochim Biophys Acta10.1016/0167-4838(88)90014-31988Allosteric Regulation, Aspartate Carbamoyltransferase/*isolation & purification/metabolism, Enzyme Stability, Kinetics, Macromolecular Substances, Molecular Weight, Mycobacterium/*enzymologyPhylogeny
Enzymology3440089Role of various carbon and nitrogen sources in the regulation of enzymes of pyrimidine biosynthesis in Mycobacterium smegmatis TMC 1546.Masood R, Venkitasubramanian TAAnn Inst Pasteur Microbiol10.1016/0769-2609(87)90036-61987Amino Acids/pharmacology, Arginine/pharmacology, Aspartate Carbamoyltransferase/antagonists & inhibitors/metabolism, Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)/metabolism, Carbohydrates/pharmacology, Carboxylic Acids/pharmacology, Culture Media, Mycobacterium/*enzymology/metabolism, Ornithine/pharmacology, Pyrimidines/*biosynthesisMetabolism
Enzymology3566963Ornithine transcarbamylase from Mycobacterium smegmatis ATCC 14468: purification, properties, and reaction mechanism.Ahmad S, Bhatnagar RK, Venkitasubramanian TABiochem Cell Biol10.1139/o86-1771986Amines/pharmacology, Arginine/pharmacology, Hydrogen-Ion Concentration, Kinetics, Molecular Weight, Mycobacterium/*enzymology, Ornithine/metabolism, Ornithine Carbamoyltransferase/antagonists & inhibitors/isolation & purification/*metabolism, Phenylglyoxal/pharmacology, Sulfhydryl Reagents/pharmacology, Valine/pharmacologyMetabolism
Pathogenicity6166835Effects of a bacteriocin from Mycobacterium smegmatis on BALB/3T3 and simian virus 40-transformed BALB/c mouse cells.Saito H, Watanabe TMicrobiol Immunol10.1111/j.1348-0421.1981.tb00002.x1981Animals, Bacteriocins/*pharmacology, Cell Line, Cell Membrane/physiology, Cell Survival/*drug effects, *Cell Transformation, Neoplastic, *Cell Transformation, Viral, DNA/biosynthesis, Lectins/pharmacology, Mice, Mice, Inbred BALB C, Protein Biosynthesis, RNA/biosynthesis, Simian virus 40, Wheat Germ Agglutinins
Metabolism6372572Growth and macromolecular synthesis of spheroplasts of Mycobacterium smegmatis ATCC 14468.Murty MV, Venkitasubramanian TAAnn Microbiol (Paris)1983Bacteriological Techniques, Cell Wall/metabolism, Culture Media, Models, Genetic, Mycobacterium/genetics/growth & development/*metabolism, Spheroplasts/*metabolismCultivation
Metabolism6508073Influence of carbon and nitrogen sources on arginine biosynthesis in Mycobacterium smegmatis ATCC 14468.Ahmad S, Bhatnagar RK, Venkitasubramanian TAAnn Microbiol (Paris)10.1016/s0769-2609(84)80021-61984Arginine/*biosynthesis/metabolism, Asparagine/metabolism, Carbon, Culture Media, Mycobacterium/enzymology/growth & development/*metabolism, Nitrogen, Ornithine/metabolismCultivation
Metabolism6508074Turnover of phospholipids and glycerides of spheroplasts of Mycobacterium smegmatis ATCC 14468.Murty MV, Venkitasubramanian TAAnn Microbiol (Paris)10.1016/s0769-2609(84)80022-81984Carbon Radioisotopes, Cardiolipins/metabolism, Glycerides/*metabolism, Mycobacterium/*metabolism/ultrastructure, Palmitic Acid, Palmitic Acids/metabolism, Phospholipids/*metabolism, Spheroplasts/*metabolism
Metabolism6516537Phospholipids and glycerides composition during spheroplasts formation of Mycobacterium smegmatis ATCC 14468.Murty MV, Venkitasubramanian TAZ Naturforsch C Biosci10.1515/znc-1984-9-10161984Carbon Radioisotopes, Glycerides/*metabolism, Kinetics, Mycobacterium/*physiology, Palmitic Acid, Palmitic Acids/metabolism, Phospholipids/*metabolism, Spheroplasts/physiologyEnzymology
Metabolism6826523Mycobacteriocins produced by rapidly growing mycobacteria are Tween-hydrolyzing esterases.Saito H, Tomioka H, Watanabe T, Yoneyama TJ Bacteriol10.1128/jb.153.3.1294-1300.19831983Bacteriocins/*metabolism, Esterases/*metabolism, Mycobacterium/*metabolism, Oleic Acid, Oleic Acids/pharmacology, Polysorbates/*metabolism
Enzymology6885719Purification and characterization of the tween-hydrolyzing esterase of Mycobacterium smegmatis.Tomioka HJ Bacteriol10.1128/jb.155.3.1249-1259.19831983Chelating Agents/pharmacology, Esterases/isolation & purification/*metabolism, Hydrogen-Ion Concentration, Kinetics, Metals/pharmacology, Molecular Weight, Mycobacterium/*enzymology, Polysorbates/*metabolism, Substrate Specificity, TemperatureMetabolism
Metabolism7419493Characterization of binding sites for a bacteriocin produced by Mycobacterium smegmatis.Watanabe T, Saito HJ Bacteriol10.1128/jb.144.1.428-431.19801980Amino Sugars/pharmacology, Bacteriocins/*metabolism, Binding Sites, Carbohydrates/pharmacology, Cell Membrane/metabolism, Cell Wall/metabolism, Glucose/pharmacology, Mycobacterium/*metabolism, Structure-Activity Relationship
Metabolism7759478Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium.Khoo KH, Dell A, Morris HR, Brennan PJ, Chatterjee DJ Biol Chem10.1074/jbc.270.21.123801995Antigens, Bacterial/*chemistry/metabolism, Arabinose/chemistry, Carbohydrate Sequence, Deuterium Oxide, Hydrolysis, Inositol Phosphates/*analysis/metabolism, Lipopolysaccharides/*chemistry/metabolism, Mannose/chemistry, Molecular Sequence Data, Mycobacterium/*chemistry/growth & development/metabolism, Mycobacterium bovis/chemistry, Mycobacterium leprae/chemistry, Mycobacterium tuberculosis/chemistry, Oxidation-Reduction, Species Specificity, Spectrometry, Mass, Fast Atom BombardmentGenetics
Pathogenicity18450455Synthesis of methyl 5-S-alkyl-5-thio-D-arabinofuranosides and evaluation of their antimycobacterial activity.Sanki AK, Boucau J, Srivastava P, Adams SS, Ronning DR, Sucheck SJBioorg Med Chem10.1016/j.bmc.2008.03.0622008Amino Acid Sequence, *Arabinose/analogs & derivatives/chemical synthesis/pharmacology, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Microbial Sensitivity Tests, Models, Molecular, Molecular Sequence Data, Mycobacterium smegmatis/*drug effects, Mycobacterium tuberculosis/*drug effects, Sequence Alignment, Structure-Activity Relationship, Sulfhydryl Compounds/*chemistryGenetics
Pathogenicity18678487Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity.Demaray JA, Thuener JE, Dawson MN, Sucheck SJBioorg Med Chem Lett10.1016/j.bmcl.2008.07.0872008Anti-Bacterial Agents/*chemical synthesis/*pharmacology, Bacillus subtilis/drug effects, Enterococcus faecalis/drug effects, Microbial Sensitivity Tests, Mycobacterium smegmatis/drug effects, Oxazolidinones/*chemical synthesis/*pharmacology, Triazoles/*chemical synthesis/*pharmacology
Pathogenicity22960551An antimicrobial evaluation of plants used for the treatment of respiratory infections in rural Maputaland, KwaZulu-Natal, South Africa.York T, van Vuuren SF, de Wet HJ Ethnopharmacol10.1016/j.jep.2012.08.0382012Anti-Infective Agents/*pharmacology, Bacteria/drug effects, Cryptococcus neoformans/drug effects, *Medicine, African Traditional, Microbial Sensitivity Tests, Plant Extracts/*pharmacology, Plants, Medicinal, Respiratory Tract Infections/drug therapy, Rural Population, South Africa
24495981Biocompatible high performance hyperbranched epoxy/clay nanocomposite as an implantable material.Barua S, Dutta N, Karmakar S, Chattopadhyay P, Aidew L, Buragohain AK, Karak NBiomed Mater10.1088/1748-6041/9/2/0250062014Animals, Anti-Infective Agents/chemistry, Biocompatible Materials/*chemistry, Candida albicans, Epoxy Compounds/chemistry, Escherichia coli, Male, Materials Testing, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Mycobacterium smegmatis, Nanocomposites/*chemistry, Polymers/chemistry, *Prostheses and Implants, Rats, Rats, Wistar, Regeneration, Spectroscopy, Fourier Transform Infrared, Staphylococcus aureus, X-Ray Diffraction
Pathogenicity24786571Antibacterial activities of plants from Central Africa used traditionally by the Bakola pygmies for treating respiratory and tuberculosis-related symptoms.Fomogne-Fodjo MC, Van Vuuren S, Ndinteh DT, Krause RW, Olivier DKJ Ethnopharmacol10.1016/j.jep.2014.04.0322014Africa, Central, Anti-Bacterial Agents/isolation & purification/*pharmacology, Bacteria/drug effects, Cameroon, Ethnopharmacology, Medicine, African Traditional/methods, Microbial Sensitivity Tests, Mycobacterium/*drug effects, Phytotherapy/methods, Plant Extracts/*pharmacology, Plants, Medicinal/*chemistry, Respiratory Tract Infections/drug therapy/microbiologyEnzymology
Pathogenicity25915607Molecular Docking Studies of the Antitumoral Activity and Characterization of New Chalcone.San-Martin A, Donoso V, Leiva S, Bacho M, Nunez S, Gutierrez M, Rovirosa J, Bailon-Moscoso N, Camacho SC, Aviles OM, Cazar MECurr Top Med Chem10.2174/15680266156661504271250332015Anti-Bacterial Agents/chemistry/pharmacology, Antineoplastic Agents, Phytogenic/chemistry/*pharmacology, Apiaceae/*chemistry, Bacteria/drug effects, Chalcones/*chemistry/*pharmacology, Free Radicals, Humans, Microbial Sensitivity Tests, Molecular Structure, Structure-Activity Relationship
Pathogenicity26749825Antimicrobial Diterpenes from Azorella Species Against Gram-Positive Bacteria.Donoso V, Bacho M, Nuinez S, Rovirosa J, San-Martin A, Leiva SNat Prod Commun2015Anti-Bacterial Agents/chemistry/*pharmacology, Apiaceae/*chemistry, Diterpenes/chemistry/*pharmacology, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Molecular Structure, Plant Extracts/chemistry/*pharmacology
Pathogenicity29733942Terminalia laxiflora and Terminalia brownii contain a broad spectrum of antimycobacterial compounds including ellagitannins, ellagic acid derivatives, triterpenes, fatty acids and fatty alcohols.Salih EYA, Julkunen-Tiitto R, Lampi AM, Kanninen M, Luukkanen O, Sipi M, Lehtonen M, Vuorela H, Fyhrquist PJ Ethnopharmacol10.1016/j.jep.2018.04.0302018Anti-Bacterial Agents/*pharmacology, Ellagic Acid/pharmacology, Fatty Acids/pharmacology, Fatty Alcohols/pharmacology, Hydrolyzable Tannins/pharmacology, Medicine, African Traditional, Microbial Sensitivity Tests, Mycobacterium smegmatis/*drug effects/growth & development, Plant Extracts/*pharmacology, Plant Structures, Sudan, *Terminalia, Triterpenes/pharmacology
Enzymology34624680Hydrolyzable tannins (ellagitannins), flavonoids, pentacyclic triterpenes and their glycosides in antimycobacterial extracts of the ethnopharmacologically selected Sudanese medicinal plant Combretum hartmannianum Schweinf.Salih EYA, Julkunen-Tiitto R, Luukkanen O, Fahmi MKM, Fyhrquist PBiomed Pharmacother10.1016/j.biopha.2021.1122642021Anti-Bacterial Agents/isolation & purification/*pharmacology, *Combretum/chemistry, Ethnopharmacology, Flavonoids/isolation & purification/*pharmacology, Glycosides/isolation & purification/*pharmacology, Humans, Hydrolyzable Tannins/isolation & purification/*pharmacology, Microbial Sensitivity Tests, Mycobacterium smegmatis/*drug effects/growth & development, Pentacyclic Triterpenes/isolation & purification/*pharmacology, Phytochemicals/isolation & purification/*pharmacology, Plant Extracts/isolation & purification/*pharmacology, SudanPhylogeny

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
10921Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 43277)https://www.dsmz.de/collection/catalogue/details/culture/DSM-43277
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
77717Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID46517.1StrainInfo: A central database for resolving microbial strain identifiers